Researchers found “type 2 innate lymphocytes” – already known to occur in the gut, lungs and skin – in membranes surrounding the brain, near where previously unknown vessels connect the brain and immune system. (Image: Sachin Gadani, School of Medicine)
University of Virginia School of Medicine researchers have discovered a rare and powerful type of immune cell in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer’s disease, multiple sclerosis, meningitis and other neurological diseases, in addition to supporting our healthy mental functioning. By harnessing the cells’ power, doctors may be able to develop new treatments for neurological diseases, traumatic brain injury and spinal cord injuries – even migraines.
Further, the researchers suspect the cells may be the missing link connecting the brain and the microbiota in our guts, a relationship already shown important in the development of Parkinson’s disease.
Unexpected Presence
The cells, known as “type 2 innate lymphocytes,” previously have been found in the gut, lungs and skin – the body’s barriers to disease. Their discovery in the meninges, the membranes surrounding the brain, comes as a surprise.
They were found as UVA researcher Jonathan Kipnis explored the implications of his lab’s game-changing discovery last year that the brain and the immune system are directly connected via vessels long thought not to exist.
niversity of Virginia School of Medicine researchers have discovered a rare and powerful type of immune cell in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer’s disease, multiple sclerosis, meningitis and other neurological diseases, in addition to supporting our healthy mental functioning. By harnessing the cells’ power, doctors may be able to develop new treatments for neurological diseases, traumatic brain injury and spinal cord injuries – even migraines.
Further, the researchers suspect the cells may be the missing link connecting the brain and the microbiota in our guts, a relationship already shown important in the development of Parkinson’s disease.
Unexpected Presence
The cells, known as “type 2 innate lymphocytes,” previously have been found in the gut, lungs and skin – the body’s barriers to disease. Their discovery in the meninges, the membranes surrounding the brain, comes as a surprise.
They were found as UVA researcher Jonathan Kipnis explored the implications of his lab’s game-changing discovery last year that the brain and the immune system are directly connected via vessels long thought not to exist.
niversity of Virginia School of Medicine researchers have discovered a rare and powerful type of immune cell in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer’s disease, multiple sclerosis, meningitis and other neurological diseases, in addition to supporting our healthy mental functioning. By harnessing the cells’ power, doctors may be able to develop new treatments for neurological diseases, traumatic brain injury and spinal cord injuries – even migraines.
Further, the researchers suspect the cells may be the missing link connecting the brain and the microbiota in our guts, a relationship already shown important in the development of Parkinson’s disease.
Unexpected Presence
The cells, known as “type 2 innate lymphocytes,” previously have been found in the gut, lungs and skin – the body’s barriers to disease. Their discovery in the meninges, the membranes surrounding the brain, comes as a surprise.
They were found as UVA researcher Jonathan Kipnis explored the implications of his lab’s game-changing discovery last year that the brain and the immune system are directly connected via vessels long thought not to exist.
“These cells are potentially the mediator between the gut and the brain. They are the main responder to microbiota changes in the gut. They may go from the gut to the brain, or they may just produce something that will impact those cells. But you see them in the gut and now you see them also in the brain,” Kipnis said. “We know the brain responds to things happening in the gut. Is it logical that these will be the cells that connect the two? Potentially. We don’t know that, but it very well could be.”
While much more research needs to be done to understand the role of these cells in the meninges, Gadani noted that it’s almost certain that the cells are important in a variety of neurological conditions.
“It would be inconceivable they’re not playing a role in migraines and certain conditions like that,” he said. “The long-term goal of this would be developing drugs for targeting these cells. I think it could be highly efficacious in migraine, multiple sclerosis and possibly other conditions.”
Learn more: UNKNOWN SOLDIERS: UVA DISCOVERS POWERFUL DEFENDERS OF THE BRAIN
[osd_subscribe categories=’immune-therapies’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “IMMUNE THERAPIES”‘]
Receive an email update when we add a new IMMUNE THERAPIES article.
The Latest on: Type 2 innate lymphocytes
via Google News
The Latest on: Yype 2 innate lymphocytes
- New Therapies on Horizon as Science of CLE Advanceson August 2, 2022 at 1:13 pm
Investigators say recent research into the development of cutaneous lupus erythematosus has created the potential for new therapies.
- Rejection of the Kidney Allografton July 20, 2022 at 5:00 pm
1,2 Rejection has ... elements include the innate immune system of natural killer cells, macrophages, and complement; the adaptive immune system of antigen-specific T lymphocytes and B cells ...
- Deficiency of Innate and Acquired Immunity Caused by an IKBKB Mutationon July 20, 2022 at 5:00 pm
Many patients with SCID have lymphocyte-activation defects that remain ... 1292dupG in exon 13 of IKBKB, which encodes IκB kinase 2 (IKK2, also known as IKKβ) — leading to loss of expression ...
- What is the association between natural killer cell dysfunction and COVID-19 disease severity?on July 20, 2022 at 1:27 am
Various studies have reported that the cytotoxic role of NK cells is adversely impacted in COVID-19 patients. While the primary immune effector cells responsible for an antiviral response are NK cells ...
- Cytotoxic T Lymphocyte Responses in HIV-1-infected Long-term Nonprogressors: Lessons for Vaccine Designon July 15, 2022 at 5:00 pm
this virus will have a relative advantage compared with wild-type virus. AIDS typically develops within 5-7 years after infection, although very rapid disease progression in less than 2 years or ...
- T-cell Lymphoma Market worth $2.89 billion by 2030 - Exclusive Report by InsightAce Analyticon July 12, 2022 at 2:24 am
JERSEY CITY, N.J., July 12, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global T-cell Lymphoma Market By Lymphoma Type ...
- Persistence of SARS-CoV-2 in tissues leads to long COVIDon July 11, 2022 at 11:36 pm
The SARS-CoV-2 infection ... Type 1 interferon (IFN1) is a potent and early cytokine released by virally infected cells. Dendritic cells (DCs) are primary immune cells that contribute to innate ...
- Relationship Between Neutrophil-lymphocyte Ratio and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Mellitus Patientson July 9, 2022 at 5:00 pm
The present study had shown that the NLR values of the diabetic patients were significantly higher than those of the healthy control (P
via Bing News